Ausgabe 2-3/2003
Inhalt (12 Artikel)
Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis
Motoharu Seiki, Naohiko Koshikawa, Ikuo Yana
Cell surface association of matrix metalloproteinase-9 (gelatinase B)
Rafael Fridman, Marta Toth, Irina Chvyrkova, Samy O. Meroueh, Shahriar Mobashery
RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling
Makoto Noda, Junseo Oh, Rei Takahashi, Shunya Kondo, Hitoshi Kitayama, Chiaki Takahashi
Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials
Maria Pavlaki, Stanley Zucker
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
Nicolai Sidenius, Francesco Blasi
Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor
Hiroaki Kataoka, Shiro Miyata, Shunro Uchinokura, Hiroshi Itoh
Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer
Sarah Netzel-Arnett, John D. Hooper, Roman Szabo, Edwin L. Madison, James P. Quigley, Thomas H. Bugge, Toni M. Antalis